Recombinant Human KIR3DS1/CD158e2 Fc Chimera Protein, CF
| Name | Recombinant Human KIR3DS1/CD158e2 Fc Chimera Protein, CF |
|---|---|
| Supplier | R&D Systems |
| Catalog | 4136-KR |
| Category | Protein |
| Prices | $329.00 |
| Sizes | 50 µg |
| Species Reactivities | Human |
| Nature | Recombinant |
| Source | Chinese Hamster Ovary cell line, CHO-derived Human KIR3DS1 (His22-His340) Accession #Q14943 IEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus |
| Purity | >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Bioactivity | Measured by its ability to bind HLA on MDA‑MB‑231 human breast cancer cells. The ED 50 for this effect is 0.03-0.18 μg/mL. |
| Endotoxin | <0.01 EU per 1 μg of the protein by the LAL method. |
| SwissProt/Accession | Q14943 |
| Gene | KIR3DS1 |
| Sequence | His22 |
| Supplier Page | Shop |
Product images
Recombinant Human KIR3DS1/CD158e2 Fc Chimera (Catalog # 4136-KR)binds to MDA-MB-231 human breast cancer cells. The ED 50 for this effect is0.03-0.18 μg/mL.